Table 2.
Items | Reference values - base-case (US$)/year | Sources | |||||
---|---|---|---|---|---|---|---|
A - Diagnosis of vivax malaria | 2009 | 2010 | 2011 | ||||
All males | Males with G6PDd 1 | All males | Males with G6PDd 1 | All males | Males with G6PDd 1 | ||
- Thick blood smear | 1,814,409.17 | 81,648.41 | 2,202,950.33 | 99,132.77 | 2,665,142.63 | 119,931.42 | [24] |
- Microscope | 1,096,068.22 | 49,323.07 | 1,280,603.64 | 57,627.16 | 1,303,580.23 | 58,661.11 | [25] |
- Microscope maintenance | 83,204.59 | 3,744.21 | 97,213.02 | 4,374.59 | 98,957.22 | 4,453.08 | [30] |
- Health workers | 3,912,989.04 | 176,084.51 | 4,754,380.68 | 213,947.13 | 5,889,094.46 | 265,009.25 | [31] |
- Annual training (microscopist) | 7,223,201.42 | 325,044.07 | 8,307,793.49 | 373,850.70 | 8,564,439.54 | 385,399.78 | [30] |
- Total costs (A) | 14,129,872.43 | 635,844.27 | 16,642.941.17 | 748,932.35 | 18,521,214.09 | 833,454.64 | |
B – Drug treatment for P. vivax | 2009 | 2010 | 2011 | ||||
All males | Males with G6PDd | All males | Males with G6PDd | All males | Males with G6PDd | ||
- Therapeutic scheme | 41,284.62 | 1,857.92 | 58,635.90 | 2,638.56 | 41,415.28 | 1,863.65 | [32] |
C – Assistance to carriers of G6PDd treated with PQ | 2009 | 2010 | 2011 | ||||
Males with G6PDd | Males with G6PDd | Males with G6PDd | |||||
- Pre-admission tests | 74,659.04 | 94,701.04 | 82,037.35 | [20,24] | |||
- Medical appointments | 66,271.36 | 83,681.82 | 72,047.90 | [20] | |||
- Hospitalization2 | 3,530,482.47 | 4,457,992.22 | 3,838,217.22 | [20] | |||
- Hospital food | 432,757.87 | 580,711.73 | 538,733.13 | [33] | |||
- Health workers | 141,826.64 | 188,506.44 | 175,245.56 | [34] | |||
- Tests performed after hospitalization | 64,235.79 | 81,530.89 | 70,688.14 | [20,24] | |||
- Total costs (C) | 4,310,233.17 | 5,487,124.14 | 4,776,969.30 | ||||
- Total costs (A + B + C)3 | 4,947,935.36 | 6,238,695.05 | 5,612,287.59 |
1Weighted by the prevalence of G6PDd (4.5%).
2In the years evaluated, 19% and 81% of the costs corresponded to hospitalization in ICT and ward, respectively.
3Males with G6PDd.